home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Regulatory Affairs Part I: The IND Phase

 
  April 01, 2010  
     
 
Drug Information Association, Inc. , Horsham, PA USA
Sep 13 2010 8:30AM - Sep 15 2010 12:15PM


All You Need to know about IND Submissions in Only 3 Days

Learn how to apply regulatory concepts to ensure compliant IND submissions to FDA. The course focuses on drug and well characterized biological products and not the regulatory process for devices, generic products, or traditional biologics.

WHAT YOU WILL LEARN

·          Overview of the drug development process

·          The IND process 

·          Quality assurance in drug development (GXPs)·          FDA’s actions on the original IND and amendments·          Activities and submissions after the original IND·          How to interact with FDA

·          Procedures for reporting adverse events (AEs)

Event Code:
10456

 
 
Organized by: Drug Information Association, Inc.
Invited Speakers: call contact
 
Deadline for Abstracts: call contact
 
Registration: For detailed program information including faculty and topics, please contact:
Susan Mazak
Tel. +1-215-442-6183
E-mail: Susan.Mazak@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.